New drug trial offers hope for kids with severe bowel disease

NCT ID NCT05784246

Recruiting now Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

Summary

This study is testing a drug called mirikizumab to see if it can help control ulcerative colitis in children and teenagers aged 2 to 18. It is for kids whose disease is moderate to severe and who haven't gotten enough help from other standard treatments. The main goal is to see if the drug can put the disease into remission and keep it under control for a year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza
COMPLETED

Roma, 00161, Italy
Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer
COMPLETED

Florence, 50139, Italy
Centrum Medyczne Oporow
COMPLETED

Wroclaw, 52-416, Poland
Children's Center for Digestive Health Care, LLC
COMPLETED

Atlanta, Georgia, 30342, United States
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States

Contact Phone: •••-•••-••••

Contact
Gabinet Lekarski Bartosz Korczowski
COMPLETED

Rzeszów, 35-302, Poland
Hadassah University Hospital, Ein Kerem
COMPLETED

Jerusalem, 911200, Israel
Helios Klinikum Wuppertal
COMPLETED

Wuppertal, 42283, Germany
Hôpital Necker - Enfants Malades
COMPLETED

Paris, 75015, France
Icahn School of Medicine at Mount Sinai
COMPLETED

New York, New York, 10029, United States
Institute of Science Tokyo Hospital
COMPLETED

Bunkyō City, 113-8519, Japan
Instytut 'Pomnik - Centrum Zdrowia Dziecka
COMPLETED

Warsaw, 04-730, Poland
Juntendo University Hospital
COMPLETED

Bunkyō City, 113-8431, Japan
King Fahad Medical City
COMPLETED

Rishon LeZiyyon, 70300, Israel
Kokikai Tsujinaka Hospital Kashiwanoha
COMPLETED

Kashiwa-shi, 277-0871, Japan
Kyungpook National University Chilgok Hospital
COMPLETED

Daegu, 41404, South Korea
LMU-Campus Innenstadt
COMPLETED

München, 80337, Germany
Medical Network Spółka z o. o., WIP Warsaw IBD Point Profesor Kierkus
COMPLETED

Warsaw, 04-501, Poland
National Center for Child Health and Development
COMPLETED

Setagaya-ku, 157-8535, Japan
Riley Childrens Hospital
COMPLETED

Indianapolis, Indiana, 46202, United States
Saga University Hospital
COMPLETED

Saga, 849-8501, Japan
Samsung Medical Center
COMPLETED

Seoul, 06351, South Korea
Schneider Children's Medical Center
COMPLETED

Petah Tikva, 4920235, Israel
Severance Hospital, Yonsei University Health System
COMPLETED

Seoul, 03722, South Korea
Shaare Zedek
COMPLETED

Jerusalem, 9103102, Israel
Sheffield Children's Hospital
COMPLETED

Sheffield, S102TH, United Kingdom
The Hospital for Sick Children
COMPLETED

Toronto, M5G 0A4, Canada
Twoja Przychodnia-Szczecińskie Centrum Medyczne
COMPLETED

Szczecin, 71-434, Poland
UZ Leuven
COMPLETED

Leuven, 3000, Belgium
UZA
COMPLETED

Edegem, 2650, Belgium
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
COMPLETED

Mainz, 55131, Germany
University of California, San Francisco
COMPLETED

San Francisco, California, 94158, United States
Washington University
COMPLETED

St Louis, Missouri, 63110-1010, United States
Yokohama City University Medical Center, Center of IBD
COMPLETED

Yokohama, 232-0024, Japan

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS